🇺🇸 FDA
Patent

US 8975029

Integrin alpha-2 binding agents and use thereof to inhibit cancer cell proliferation

granted A61KA61K2039/505A61P

Quick answer

US patent 8975029 (Integrin alpha-2 binding agents and use thereof to inhibit cancer cell proliferation) held by THE REGENTS OF THE UNIVERSITY OF MICHIGAN expires Mon Mar 05 2035 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
THE REGENTS OF THE UNIVERSITY OF MICHIGAN
Grant date
Tue Mar 10 2015 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Mar 05 2035 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
10
CPC classes
A61K, A61K2039/505, A61P, A61P35/00, A61P43/00